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Abstract
Allicin (diallyl thiosulfinate) is the main biologically active component of the freshly crushed garlic extracts. In the present
work the ability of allicin to cross through membranes (artificial and biological) was studied. Partition coefficients of allicin
in water/octanol, water/hexadecane and water/phospholipids mixtures were determined. Using phospholipid vesicles loaded
with hydrophilic thiols (reduced glutathione or 2-nitro-5-thiobenzoate), we observed that allicin freely permeates through
phospholipid bilayers and interacts with the SH groups. The reaction rate of allicin with SH containing molecules after
crossing the membrane was the same as in solution. Fast diffusion and permeation of allicin across human red blood cell
membranes was also demonstrated. Allicin does not induce leakage, fusion or aggregation of membrane. The high
permeability of allicin through membranes may greatly enhance the intracellular interaction with thiols. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Many bene¢cial health related biological e¡ects of
garlic (Allium sativum) are attributed to its character-
istic organosulfur compounds [1^4]. The best known
and most extensively studied is allicin (diallyl thio-
sul¢nate), the principal active substance of fresh gar-
lic extract, which is responsible for garlic’s typical
pungent smell. Allicin is produced according to
Scheme 1, during the crushing of garlic cloves by
the interaction between the non-protein amino acid
alliin and the enzyme alliinase [5].
Allicin is a precursor of a number of secondary
products formed in aged garlic and crushed garlic
preparations. Allicin possesses various biological ac-
tivities among which antibacterial, antifungal and
antiparasitic e¡ects are included [1^12]. In addition
to that it reduces serum cholesterol and triglyceride
levels as well as atherosclerotic plaque formation and
platelet aggregation, it inhibits cancer promotion and
decreases ocular pressure [1^3,13]. Allicin rapidly dis-
appears after injection into the blood [14,15]. This
rather unstable compound has been suggested by
Lawson anc coworkers to transform rapidly into sec-
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ondary products (in vivo), such as allylmercaptan
and others [2,14]. At present a variety of biological
e¡ects of allicin is attributed to both antioxidant ac-
tivity and modi¢cation of SH-dependent activities
[16,17]. These activities have been con¢rmed by us
in model systems [18,19]. Recently the inhibitory ef-
fect of allicin on NO formation was also demon-
strated [20]. In addition to that, allicin a¡ects the
processing of DNA and RNA synthesis [11], signal
transduction and apoptosis. All the e¡ects described
above are mainly intracellular. Therefore the ques-
tion arose: how does allicin permeate through the
plasma membrane and take part in intracellular
processes? In the present work we studied the per-
meability of allicin through lipid bilayers of phos-
pholipid vesicles as well as through natural mem-
branes of red blood cells (RBCs), using its
interaction with internally entrapped thiol containing
compounds such as glutathione (GSH) or 2-nitro-5-
thiobenzoate (NTB).
2. Materials and methods
L-Cysteine, reduced glutathione, oxidized gluta-
thione, dimyristoylphosphatidylcholine (DMPC),
calcein and 5,5P-dithiobis-(2-nitrobenzoic acid)
(DTNB) were purchased from Sigma Chemical Co.
(St. Louis, MO, USA). Egg phosphatidylcholine
(PC) was purchased from Lipid Products (South
Nut¢eld, UK). Cholesterol (extra pure) was from
Merck (Darmstadt, Germany). Allicin was prepared
enzymatically from synthetic alliin and puri¢ed by
HPLC [18]. NTB was prepared according to [21].
Symmetrical stable nitroxyl biradical containing di-
sul¢de bond, bis(2,2,5,5-tetramethyl-3-imidazoline-1-
oxyl-4-yl) disul¢de (Biradical), synthesized according
to [22], was a kind gift of Dr. V. Martin (Lipitek Int.
Inc., San Antonio, TX, USA). All other reagents
were of analytical grade.
2.1. Synthesis and isolation of a
S-allylmercaptoglutathione (GSSA)
The reaction between allicin and GSH was per-
formed using an excess of allicin. GSH (200 mg in
5 ml water, pH 6.0) was added dropwise to allicin
(130 mg), dissolved in 50% methanol (2 ml) and kept
at room temperature for 2 h. The product of the
reaction was detected by HPLC analysis. Excess alli-
cin was removed by extraction with ether. The water
phase was dried by lyophilization. The product was
re-dissolved in water and dried again by lyophiliza-
tion. The structure was con¢rmed by NMR and MS.
2.2. Assay of free sulfhydryl groups
Determination of free sulfhydryl groups was done
with DTNB by using OM 14 150 M31 cm31 at 412 nm
according to [23]. Determination of free SH in hu-
man RBCs was also done with Biradical using elec-
tron spin resonance (ESR) as described by Weiner
[24].
2.3. Determination of partition coe⁄cient of allicin
Determination of partition coe⁄cients of allicin in
phospholipids, octanol and hexadecane was done ac-
cording to [25]. Brie£y, allicin (6.5 mM, 250 Wl) in
0.05 M Na phosphate bu¡er (pH 6.5) was added to
dry lipid (10 mg) or solvent (10 Wl). The allicin/lipid
dispersions were homogenized by vortexing and
shaking for 1 h at 37‡C (in the case of phospholipid)
or at room temperature (in the case of the solvents).
The amount of remaining allicin in the water phase
was determined by HPLC. The partition coe⁄cient
(Kp) of allicin (solvent/water or lipid/water) was de-
¢ned as follows:
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where [allicin]lipid = [allicin]total3[allicin]water, Vwater
and Vlipid are the volumes of the water phase and
the lipid or solvent phase respectively.
2.4. Separation of alliin, allicin and GSSA by HPLC
Quantitative determinations of alliin, GSSA and
allicin were performed in an LKB HPLC system
with the SP 4290 integrator (Spectraphysics). The
separation was achieved on a LiChrosorb RP-18 (7
Wm) column using 60% methanol in water containing
0.1% formic acid as an eluant. Flow rate was 0.56
ml/min.
2.5. Determination of rate constants
The rate constant for the reaction of allicin and
GSH was obtained in 0.1 M NaCl, 0.01 M Na phos-
phate bu¡er (pH 7.0). The initial rate of GSSA ap-
pearance was monitored by HPLC. At various time
intervals, samples were diluted with HPLC running
bu¡er and analyzed by HPLC. For calculation the
following equation was used:
dGSSA=dt  K AllicinUGSH 2
where d[GSSA]/dt is the initial rate of GSSA appear-
ance, K is the bimolecular rate constant, [Allicin] and
[GSH] are the initial concentrations of allicin and
GSH.
The rate constant for the reaction of allicin and
NTB at pH 7.0 was obtained from the product for-
mation dependence on temperature. The concentra-
tion ranges used were: NTB (1^7)U1035 M, allicin
(2^30)U1036 M. The reaction was carried out in a
thermostated reaction cell in a HP8453 spectropho-
tometer under constant mixing.
2.6. Preparation of phospholipid vesicles
Small unilamellar phospholipid vesicles (SUV)
were made either from egg phosphatidylcholine
(PC) or from dimyristoylphosphatidylcholine
(DMPC) and cholesterol. In the case of SUV made
from PC, the concentration of cholesterol was 17%
mol/mol. In the case of SUV made from DMPC,
cholesterol content was 25% mol/mol. Cholesterol
was dissolved in CHCl3/MeOH (2:1 v/v). The choles-
terol solution was added to the dry lipid. A ¢lm of
2.5^5 mg lipid/glass vial was prepared by evaporating
the solvents under a stream of nitrogen, followed by
3 h drying under high vacuum. SUV containing ei-
ther GSH, calcein, calcein-cobalt complex, EDTA, or
NTB were obtained by sonication according to [26].
SUV containing GSH were prepared as follows:
GSH solution (0.2 M in 0.05 M NaCl, pH 7.0) was
added to the dried ¢lm, mixed by vortex and soni-
cated for 10^30 min in a bath-type sonicator
(G1125SP1, Laboratory Supplies Co. Inc., New
York, NY, USA). Final phospholipid concentration
was either 5 or 10 mg/ml. Other vesicles were pre-
pared in a similar way. Solutions used were of the
following concentrations: 0.1 M Na2CO3 (pH 7.0)
containing calcein 60 mM or 60 mM calcein plus
160 mM CoSO4 ; 0.03 M NaCl containing EDTA
0.25 M (pH 8); 0.03 M NaCl in 0.01 M Na phos-
phate bu¡er (pH 7.0) containing 50 mM NTB.
2.7. Gel ¢ltration
Separation of SUV from free reagents was done by
gel ¢ltration on Sephadex G-50 (15 ml bed volume)
pre-equilibrated with 0.1 M NaCl in 0.01 M Na
phosphate bu¡er (pH 7.0). In the experiments with
calcein-cobalt complex and EDTA, the gel was equi-
librated with 0.2 M NaCl in 10 mM Na phosphate
bu¡er (pH 7.0). Vesicles were eluted in the void vol-
ume and were monitored by absorption at 340 nm.
2.8. Measurements of leakage, fusion and aggregation
of liposomes
Allicin was tested for its potency to cause leakage
from SUV. These experiments were performed with
vesicle entrapped calcein, the £uorescent probe [27].
The intrinsic £uorescence of entrapped and water
diluted calcein was monitored by Shimadzu RF-540
spectro£uorometer. Excitation wavelength was 490
nm, emission range 500^600 nm. A £uorescence as-
say was performed to check the possible fusogenic
e¡ect of allicin on SUV [28]. For this purpose SUV
(DMPC/cholesterol) loaded with EDTA and gel ¢l-
tered through Sephadex G-50 column (equilibrated
with 0.2 M NaCl, 0.01 M Na phosphate bu¡er (pH
7.0) were mixed with SUV (DMPC/cholesterol), pre-
loaded with a complex of cobalt-calcein and gel ¢l-
tered through Sephadex G-50 column equilibrated
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with 0.2 M NaCl, 0.01 M Na phosphate bu¡er (pH
7.0). The £uorescence was monitored for a few mi-
nutes before adding allicin (baseline), and until 4 min
after adding it to the vesicle mixture (1034 M ¢nal
concentration). At the end of the experiment Triton
X-100 (0.2% ¢nal concentration) was added to de-
stroy the vesicles and to get the full value of £uores-
cence. There was no constant mixing of the sample in
the spectro£uorometer cell.
2.9. Preparation of red blood cells
Fresh human blood (in the presence of heparin)
was washed three times with phosphate bu¡ered sal-
ine (PBS). RBCs were collected after centrifugation
(2000 rpm, 5 min) and resuspended in PBS. A 10%
or 1% (v/v) suspension of RBC in PBS was used in
the experiments.
2.10. ESR experiments
Measurements were performed in a £at cell of the
Bruker ER-200 D-SRC spectrometer. The experi-
mental conditions included the following: ¢eld,
3500 G; sweep width, 100 G; receiver gain,
2U105 ; microwave power, 20 mW; modulation am-
plitude, 0.8 G.
2.11. NMR spectroscopy
NMR spectra were collected on a Bruker AMX-
400 spectrometer. The product of the interaction be-
tween allicin and glutathione was dissolved in deu-
terated water. 1H and 13C spectra were collected at
25‡C. Structure analysis of the product obtained was
performed as described previously [18,19]
2.12. Light scattering measurements
The size of SUV was measured by the quasi-elastic
light scattering (QELS) technique as described in
[29]. Thin-wall cylindrical cells (outer diameter, 10
mm) were employed and measurements were per-
formed at 0.5 mg of lipid/ml at 22‡C. Allicin and
the bu¡er solution were ¢ltered prior to measure-
ments using 0.22 Wm pore diameter Durapore ¢lters
(Millipore Corporation, Bedford, MA).
3. Results
3.1. Determination of partition coe⁄cients (Kp) for
allicin in lipid/H2O and organic solvent/H2O
Knowledge of the partition coe⁄cient in a lipid/
water mixture is a valuable parameter for evaluation
of possible interactions of various compounds with
lipid membranes. We measured the Kp of allicin in
octanol/H2O, hexadecane/H2O and two phospholi-
pids (PC and DMPC)/H2O mixtures. Kp values, cal-
culated according to Eq. 1 are presented in Table 1.
In the case of PC or DMPC, the measurements were
Scheme 2.
Table 1
Partition coe⁄cients (Kp) for allicin in phospholipid/H2O and
organic solvents/H2O
Lipid or solvent Temperature (‡C) Kp
DMPC 37 4.36 þ 0.50
Hexadecane 24 1.77 þ 0.31
Octanol 24 12.35 þ 1.06
PC 37 10.97 þ 0.39
The results represent the mean value of three independent ex-
periments.
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performed at temperatures maintaining the phospho-
lipids in the liquid crystalline state. According to
these data, allicin is a fairly hydrophobic agent,
easily dissolved in octanol as well as in the two phos-
pholipids used in this work, and less soluble in hexa-
decane.
3.2. Reaction of allicin with GSH
SUV containing GSH were prepared in order to
show allicin’s propensity to permeate the lipid bilayer
membrane. GSH, the main intracellular thiol of
mammalian cells, is highly hydrophilic and therefore
cannot pass lipid membranes [30,31]. GSH, like other
thiols [6,18,19], reacts rapidly with allicin as pre-
sented in Scheme 2.
The reaction between GSH and allicin was fol-
lowed by HPLC and the product was characterized
by 1H and 13C NMR as described earlier [18,19]. The
elution peak of the reaction product, GSSA (reten-
tion time 5.3 min), is positioned between that of
allicin (retention time 8 min) and GSH (retention
time 4.6 min). The kinetics of the reaction between
GSH and allicin (V2:1 ratio) in water is shown in
Fig. 1. Formation of the product and disappearance
of allicin were determined at various time intervals.
The reaction was also monitored at di¡erent concen-
trations of allicin and GSH and at di¡erent temper-
atures, bimolecular rate constant values, calculated
according to Eq. 2, are presented in Table 2.
3.3. Interaction of allicin with GSH entrapped in SUV
Allicin reacts with GSH entrapped in liposomes at
a high rate. The rate of GSSA formation in the
vesicles (Table 2) was only slightly slower than in
solution. The vesicle composition, DMPC or PC,
shows no signi¢cant e¡ect on allicin permeability.
A decrease in temperature to less than 23‡C, below
the phase transition of DMPC/cholesterol vesicles,
did not hinder allicin penetration. These ¢ndings in-
dicate that allicin permeates very easily through the
lipid bilayers.
3.4. The reaction of allicin with NTB
Monitoring of the allicin interaction with GSH by
HPLC has the disadvantage of inaccurate initial rate
measurements of the reaction during the ¢rst 5^15 s
(at pH 7.0). Therefore we used NTB as a hydrophilic
colorimetric reagent which not only reacts with alli-
cin (according to Scheme 2 [19]) but also stays within
the vesicle, not being able to penetrate through the
phospholipid bilayer [32]. The kinetics of the reaction
can be measured immediately after mixing of allicin
with NTB. The kinetics of the decrease in NTB ab-
sorbance was monitored at di¡erent concentrations
of allicin and NTB, at two temperatures, 12‡C and
30‡C, in solution and in vesicles containing NTB (see
Fig. 2). The bimolecular rate constants of the reac-
tion of NTB with allicin are presented in Table 3.
3.5. E¡ect of allicin on leakage, fusion and
aggregation of vesicles
The reaction of allicin with SH reagents located in
the internal volume of the vesicles raises the question
whether allicin a¡ects the membrane integrity, and
Table 2
Bimolecular rate constants for the reaction of allicin with GSH entrapped in phospholipid vesicles or in solution
[GSH] 1033 M Allicin 1033 M Temperature (‡C) K (M31 s31)
Solution 0.22 0.80 4 26.28 þ 1.25 (3)
0.22 0.80 24 48.66 þ 2.45 (3)
0.42 0.58 35 88.13 þ 5.32 (3)
Vesicles : DMPC/cholesterol 3:1 mol/mol 0.18 2.90 10 21.29 þ 2.20 (2)
0.34 1.35 15 23.38 þ 2.75 (2)
0.34 1.35 24 33.57 þ 4.95 (2)
0.34 1.35 35 78.45 þ 4.13 (2)
PC:cholesterol 5:1 mol/mol 0.16 1.92 24 30.40 þ 2.47 (2)
0.11 0.68 24 31.28 þ 3.15 (2)
Reaction was performed in 0.1 M NaCl, 0.01 M Na phosphate bu¡er (pH 7.0). The results are the mean values of n independent ex-
periments, as indicated in parentheses.
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whether it perturbs the structure of the bilayers.
Membrane active compounds most commonly in-
duce membrane fusion and leakage. To test the pos-
sibility of fusion and/or leakage of vesicles, we exam-
ined the e¡ect of allicin on the permeability of
DMPC/cholesterol vesicles using calcein loaded in
vesicles. If calcein is entrapped in lipid vesicles at a
high concentration, it displays a very low £uores-
cence intensity due to self quenching. As the probe
is released from the vesicles, the local concentration
of calcein decreases and the amplitude of the £uo-
rescence signal increases, due to the dilution of cal-
cein in the bulk surrounding phase. This technique
enabled us to show that there was no leakage from
DMPC/cholesterol vesicles in the absence and pres-
ence of 1U1033 M allicin (data not shown). For
testing allicin e¡ects on fusion of vesicles, we used
vesicles loaded either with Co(II)-calcein or with
EDTA [28]. No signi¢cant £uorescence was observed
when allicin was injected into the solution containing
the mixture of these vesicles (Fig. 3). However, addi-
tion of Triton X-100 (¢nal concentration 0.2%) to
Fig. 3. Addition of allicin to a mixture of liposomes (DMPC/
cholesterol 3:1 mol/mol) containing either EDTA or calcein-co-
balt. Arrows show the time of injection of allicin and Triton X-
100 respectively.
Table 3
Bimolecular rate constants of the reaction of allicin with NTB







12 49.63 þ 2.89 27.06 þ 1.14
30 119.76 þ 5.69 79.44 þ 5.39
Reaction was performed in 0.1 M NaCl, 0.01 M Na phosphate
bu¡er (pH 7.0). The results are the mean value of three inde-
pendent experiments.
Fig. 2. Kinetics of the reaction of allicin and NTB in liposomes
(DMPC/cholesterol 3:1 mol/mol) as a function of temperature.
Allicin/NTB at 12‡C (8), allicin/NTB at 30‡C (a). The initial
NTB concentration in the liposomes was 27 WM, that of allicin
was 7.2 WM.
Fig. 1. Kinetics of the reaction of allicin with GSH, monitored
by appearance of S-allylmercaptoglutathione (a) and disappear-
ance of allicin (b). The initial concentration of GSH was 1.2
mM and that of allicin 0.7 mM. The reaction was carried out
at pH 7.0.
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the mixture caused a drastic increase of £uorescence
(see Fig. 3). These results show that allicin by itself
has no e¡ect on leakage and fusion of vesicles. The
possibility of leakage from internal volume of
vesicles containing either GSH or NTB after treat-
ment of the SUV with allicin was also examined. The
control experiment was done as follows: vesicles con-
taining GSH were reacted with allicin (1U1033 M)
for 1 min at 15‡C and GSSA was determined. A
freshly prepared cysteine solution (1U1032 M) was
added to block external allicin and the mixture was
gel ¢ltered at room temperature on Sephadex G-50
as described in Section 2. GSSA was determined
again in the SUV fractions. The results, shown in
Table 4A (DMPC/cholesterol vesicles), indicate that
no signi¢cant leakage nor pore formation was ob-
served in the vesicles after allicin treatment. The
same experiment was then performed with PC/cho-
lesterol vesicles containing GSH at pH 7.0. No sig-
ni¢cant leakage was observed in this case either (Ta-
ble 4B).
QELS was used to investigate if allicin causes ag-
gregation of vesicles. QELS measurements show that
allicin has no e¡ect on the size of vesicles at the
concentration of 1.5U1033 M. This ¢nding shows
that allicin does not cause aggregation of vesicles at
the concentration used in this experiment.
3.6. Interaction of allicin with red blood cells
Red blood cells are naturally occurring membrane
vesicles in which GSH is present at a concentration
of 1^2 mM [24,33]. The amount of thiols in PBS
washed human RBC was measured either by the
noninvasive ESR technique with Biradical developed
earlier by Weiner [24], or directly after TCA precip-
itation of the RBC and assay with DTNB at pH 7.0
(Table 5). The total concentrations of thiol contain-
ing compounds estimated by the two independent
methods were very similar (about 2 mM) and are
in a good agreement with data reported by others
Table 5
Concentration of intracellular thiols (R-SH) determined in hu-
man RBC
Method [R-SH] in human RBC
Biradical (ESR) 1.78U1033 M þ 0.20
DTNBa 1.69U1033 M þ 0.34
The results are means of three independent experiments.
aAssay of R-SH was done after protein TCA precipitation of
RBC suspension, and neutralization of the supernatant to pH
7.0 with NaOH.
Table 4
Recording of the reaction product GSH+allicin, after gel ¢ltration of vesicles containing GSH treated with allicin
Vesicles [GSSA] in vesicles 1033M Yield (%)
A. DMPC/cholesterol (3:1 mol/mol, 10 mg phospholipid/ml)
Before second gel ¢ltration 0.404 100
After second gel ¢ltration 0.375 92.8
B. PC:cholesterol (5:1 mol/mol, 5 mg phospholipid/ml)
Before second gel ¢ltration 0.278 100
After second gel ¢ltration 0.234 79.9
Fig. 4. Estimation of concentration of intracellular thiols under
incubation, as a function of allicin added. Concentration of SH
groups was estimated by ESR with Biradical in RBC suspen-
sion (1%) (see Section 2).
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[33,34]. The advantage of the ESR method is that it
enables us to monitor the decrease of thiol concen-
tration in cells after short exposure to allicin. Allicin
(up to 2.5U1035 M ¢nal concentration) was added
to a 1% washed RBC suspension in an Eppendorf
tube. After 1^2 min at room temperature, the Birad-
ical was added (1034 M ¢nal concentration) and the
content of residual thiol concentration was moni-
tored. Allicin penetrates through the RBC membrane
and reacts with intracellular thiols in a concentration
dependent manner as shown in Fig. 4.
3.7. Identi¢cation of reaction products
Washed human RBC were treated at 37‡C with
allicin (5U1034 M). At di¡erent time intervals, a
fresh solution of cysteine (20 mM ¢nal concentra-
tion) was added to block external allicin, and the
suspension was washed three times with PBS. The
washed RBC were treated with TCA (¢nal concen-
tration 5%), mixed by vortexing and centrifuged. The
supernatant was diluted 1:12.5 with HPLC running
bu¡er and analyzed by HPLC. The main product
appeared as GSSA, which was formed immediately
after allicin penetration into the RBC (Fig. 5). In this
experiment, allicin was not in excess with respect to
internal thiols.
3.8. E¡ect of allicin on RBC leakage
Allicin (1U1034 M) was added to RBC (10%) at
room temperature, and at various time intervals (up
to 1 h) samples were removed and spun down. The
spectra of the supernatants were determined. Control
experiments without allicin were run under the same
condition. No leakage of hemoglobin to the super-
natant was observed. Moreover, the color of the red
blood cell pellet changed to brown during the incu-
bation with allicin, which might indicate that allicin
penetrates the membrane [15].
The fact that there is no leakage of hemoglobin
does not exclude the possible release of GSH during
treatment of RBC with allicin. A control experiment
was carried out in which RBC were treated with
allicin (0.5U1034 M) in the presence of DTNB
(1U1034 M) for 15 min at room temperature. The
RBC were sedimented and the absorbance at 412 nm
of the supernatant was determined. No absorbance
of NTB (the reaction product of GSH or cysteine
with DTNB) and no GSSA were observed in the
supernatant.
4. Discussion
We have recently shown that the bene¢cial e¡ects
of allicin on health may stem from its interaction
with SH containing molecules such as enzymes and/
or its high antioxidant activity [10,18,19]. Free thiol
containing compounds are usually intracellular, since
extracellular thiols are in most cases oxidized to di-
sul¢de by the environmental molecular oxygen.
Therefore we investigated the manner in which allicin
can penetrate cell membranes and interact with intra-
cellular thiols. Low molecular weight thiol contain-
ing compounds such as GSH and NTB were en-
trapped in lipid vesicles and red blood cells were
used as natural containers of GSH. Thus the inter-
action of the above compounds with externally
added allicin could be studied. Based on the kinetics
of this reaction, it was clearly shown that the inter-
action of allicin with the low molecular weight thiols
entrapped in the vesicles was not dependent on the
release of GSH and NTB from vesicles, since the
reaction product, GSSA, was detected in the vesicle
Fig. 5. Kinetics of appearance of GSSA in RBC at 37‡C after
treatment with allicin. Allicin treated RBC were washed with
cysteine and PBS to remove external allicin, then treated with
TCA. The concentration of GSSA was assayed in the superna-
tant.
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fraction after gel ¢ltration at the end of the reaction
(see Table 4).
Comparison of the rates of reaction of allicin with
GSH and NTB in solutions with the rates of reaction
of these thiols incorporated into internal volume of
vesicles (Tables 2 and 3) showed that the lipid mem-
brane decreased the rate of reaction not more than
1.8 times, indicating that allicin easily di¡used into
the internal volume of the vesicles. Furthermore it
was also shown that the kinetics of allicin penetra-
tion into arti¢cial vesicles at di¡erent temperatures is
independent of the phase state of the lipids and has
no e¡ect on its interaction rate with thiols1. Below
and above the phase transition of DMPC vesicles,
the rate of the chemical reaction has the same tem-
perature dependence as in solution (see Tables 2 and
3).
This behavior of allicin is very di¡erent from the
permeability of the small charged molecule superox-
ide (O32 radical) or the hydrophilic glucose molecule
into vesicles formed from synthetic lipids. Signi¢cant
di¡erences in the rate of penetration were observed
for these molecules at temperatures below and above
the phase transition temperature [38,39]
The mechanism of penetration of small molecules
through hydrophobic membrane barriers is still
under debate [40,41]. It is assumed that for nonpolar
molecules, the major permeation resistance is the
barrier rigidity near the membrane surface [42]. We
detected no resistance to allicin permeation, which
proves barrier rigidity to have no e¡ect, even in the
presence of 50% cholesterol.
Permeability coe⁄cients of small hydrophobic
molecules in membranes correlate quite well with
oil/water partition coe⁄cients. The so-called Overton
rule [43], known for almost 100 years, has been veri-
¢ed in numerous experimental systems [41]. For es-
timation of the permeability coe⁄cient of allicin
through the lipid bilayer we studied its partition in
an organic solvent/water system [41]. Using the ob-
served value for Kp (Table 1) in a hexadecane/water
system, we calculated the allicin permeability coe⁄-
cient: PV0.2 cm s31. This calculation was based on
the known dependence of permeability coe⁄cients on
hexadecane/water partition coe⁄cients (shown for a
number of low molecular weight compounds and
their permeability through RBC membranes) [41].
This value is comparable with the permeation coef-
¢cient for n-alkanes [41] but is higher than the per-
meability coe⁄cient for water (2.3U1033 cm s31)
and peroxynitrite (ONOO3) (8.0U1033 cm s31)
[44], or iodoantipyrine (V1033 cm s31) [45].
For the estimation of the di¡usion coe⁄cient of





where P is the permeability coe⁄cient, Kp the parti-
tion coe⁄cient, V the thickness of the hydrocarbon
region of membrane and Dmem the di¡usion coe⁄-
cient within the membrane. (This equation holds for
the simplest model, in which the membrane interior
is homogeneous and is the rate limiting barrier for
transmembrane movement.) Using V= 50 Aî we ob-
tained a value of Dmem for allicin of V5U1038 cm2
s31. Interestingly, this value of Dmem is very close to
the known values for di¡usion of nonpolar low mo-
lecular weight compounds with molecular weights 2^
3 times lower than allicin [41].
In conclusion, the data presented here clearly show
that allicin can easily di¡use into the internal volume
of vesicles or into the cytoplasm of red blood cells.
Lipid bilayers do not constitute a barrier for allicin
penetration and its di¡usion through the lipid bilayer
does not cause membrane leakage, fusion or aggre-
gation. In the case of RBC, there was no creation of
pores by allicin in the plasma membrane. These ¢nd-
ings raise the possibility that in biological systems
allicin can penetrate very rapidly into di¡erent com-
partments of the cells and exert its biological e¡ects.
Thus, the signi¢cance of allicin as a biological e¡ec-
tor molecule is due not only to its high reactivity
with low and high molecular weight thiols and its
prominent antioxidant activity [10,18,19], but also
to its accessibility resulting from high membrane per-
meability.
1 Introduction of cholesterol to arti¢cial lipid vesicles broadens
the gel-to-liquid crystalline phase transition as well as decreasing
the transition enthalpy [35]. However, in the case of DMPC lipo-
somes containing 25 mol% of cholesterol, as was used in this
work, the characteristics of phase transition were observed
[36,37].
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